tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
RGLS is currently covered by 3 analysts with an average price target of $15.35. This is a potential upside of $13.88 (944.22%) from yesterday's end of day stock price of $1.47.
Regulus Therapeutics's activity chart (see below) currently has 21 price targets and 36 ratings on display. The stock rating distribution of RGLS is 91.67% BUY and 8.33% HOLD.
Analysts average stock forecasts to be materialized ratio is 29.29% with an average time for these price targets to be met of 89.5 days.
Highest price target for RGLS is $10, Lowest price target is $3, average price target is $15.35.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 11-Nov-2024. First documented stock forecast 22-Oct-2014.
Currently out of the existing stock ratings of RGLS, 11 are a BUY (91.67%), 1 are a HOLD (8.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$10
$8.53 (580.27%)
$10
12 days ago
(11-Nov-2024)
1/11 (9.09%)
$8.59 (609.22%)
255
Hold
$3
$1.53 (104.08%)
8 months 10 days ago
(13-Mar-2024)
1/4 (25%)
$0.57 (23.46%)
139
Buy
$12
$10.63 (775.91%)
1 years 2 months 3 days ago
(21-Sep-2023)
0/1 (0%)
$10.71 (830.23%)
Hold
$4.2
$2.73 (185.71%)
$48
2 years 10 months 2 days ago
(21-Jan-2022)
2/3 (66.67%)
$1.96 (87.50%)
63
Hold
$30
$28.53 (1940.82%)
6 years 3 months 9 days ago
(14-Aug-2018)
3/4 (75%)
$-1.56 (-4.94%)
80
What is RGLS (Regulus Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on RGLS (Regulus Therapeutics) with a proven track record?
Which analyst has the current lower performing score on RGLS (Regulus Therapeutics) with a proven track record?
Which analyst has the most public recommendations on RGLS (Regulus Therapeutics)?
Which analyst is the currently most bullish on RGLS (Regulus Therapeutics)?
Which analyst is the currently most reserved on RGLS (Regulus Therapeutics)?
